Laboratory monitoring for HIV disease in resource-limited settings has now become one of the key challenges for antiretroviral treatment (ART) access and success, as emphasized by the 2010 revised WHO ...

SANTA CLARA, Calif--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for ...

This table pertains to laboratory tests done to select an ARV regimen and monitor for treatment responses or ART toxicities. Please refer to the HIV Primary Care guidelines for guidance on other ...

Please provide your email address to receive an email when new articles are posted on . Few adverse events were reported in OPAT containing cefazolin and ceftriaxone. Only 2.7 clinically significant ...

On Thursday, March 25, San Diego Mayor Dick Murphy and City Council members Michael Zucchet and Scott Peters led a formal ribbon-cutting for the city's Metropolitan Wastewater Department's new ...

Numerous technical challenges others than the serological diagnosis, the counting of CD4 T lymphocytes and the viral load measurements exist in the field of the biological monitoring of HIV infection ...